NEWS

The study showed that connected inhalers, which use Bluetooth sensors that attach to participants' asthma inhalers to detect medication use and share the data with physicians, may promote adherence to recommended controller medication use and proactively detect worsening of asthma symptoms.; "Emerging connected technologies can help improve patient health, with this randomised-controlled clinical trial showing that pediatric asthma patients with access to inhaler sensors report better asthma control and quality of life than patients who only received a standardized asthma education curriculum," said lead author Ruchi Gupta from Northwestern University.

Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.; Emerging connected technologies can help improve patient health, with this randomized-controlled clinical trial showing that pediatric asthma patients with access to inhaler sensors report better asthma control and quality of life than patients who only received a standardized asthma education curriculum," -- Dr. Ruchi Gupta, Study Lead and Professor of Pediatrics, Feinberg School of Medicine, Northwestern University

Sensor-based inhalers integrated into health care providers' clinical workflows may help improve medication adherence and support children with asthma - and their families - to more effectively manage this condition, according to a new Northwestern and Lurie Children's study published in Pediatrics.; "Emerging connected technologies can help improve patient health, with this randomized-controlled clinical trial showing that pediatric asthma patients with access to inhaler sensors report better asthma control and quality of life than patients who only received a standardized asthma education curriculum," said study lead Dr. Ruchi Gupta, professor of pediatrics at Northwestern University Feinberg School of Medicine, physician at Ann & Robert H. Lurie Children's Hospital of Chicago and the Director of the Center for Food Allergy & Asthma Research (CFAAR).

Peanut allergies are typically considered a problem for children, but new research shows that many adults are now developing the potentially life-threatening allergy; Nancy Chen reports for CBS2.; "This was actually really suprising for us, that adults are developing more food allergies." Study author Dr. Ruchi Gupta says it could have to do with microorganisms that make up the microbiome of the gut, as well as infections that alter the immune system, and hormonal changes.

Many people automatically think of children when they hear the phrase 'peanut allergy.' However, new research showed that this common food allergy already affected approximately 4.5 million adults in the U.S.; Researcher Dr. Ruchi Gupta said per U.S. News that Palforzia, currently the only peanut allergy drug approved by the FDA, is only recommended for pediatric patients.

Peanut allergy affects at least 4.5 million adults in the U.S., many of whom report developing their first allergy symptoms during adulthood, reports a new Northwestern Medicine study.; "Currently, the sole FDA-approved peanut allergy therapy--Palforzia-- is only indicated for pediatric patients. Given the high prevalence of peanut allergy among U.S. adults, additional therapies are needed to help address this growing burden of dise-> View it--> https://www.newkerala.com/news/2021/24673.htm

People often think of peanut allergy as a condition that primarily afflicts children. Considered as one of the most common food allergies among children in the U.S., only about 20% of those who have a peanut allergy eventually outgrow it, the American College of Allergy, Asthma & Immunology (ACAAI) said.; Dr. Ruchi Gupta, director of the Center for Food Allergy and Asthma Research at Northwestern University in Illinois and co-author of the study, explained to CNN that adults who have had a reaction to certain foods tend to avoid it instead of getting an allergy test to confirm the allergic reaction.

Around 32 million people in the U.S. have one or more food allergies, and 200,000 are hospitalized each year because of it, according to the Food Allergy Research & Education organization. A new study published in The Journal of Allergy and Clinical Immunology concludes that the current precautionary allergen labels on food products need to be updated since food shoppers are not fully aware of them and it could lead to the purchase of food they are sensitive to or allergic to.; One of the study's authors, Dr. Ruchi Gupta, director of the Center for Food Allergy & Asthma Research and a professor of pediatrics and medicine at the Northwestern Feinberg School of Medicine, says allergens used in ingredients are required by law to be listed on food packaging, but precautionary allergen labels like "may contain" or "manufactured on shared equipment" are completely voluntary.

Research from The Journal of Allergy and Clinical Immunology shows there are 4.6 million adults around the nation who are allergic to the legume and many – 800,000 of them – developed it in adulthood, CNN reported.; Dr. Ruchi Gupta, the study's author and director of the Center for Food Allergy and Asthma Research at Northwestern University in Illinois, said that peanut allergies are generally thought to be a pediatric issue, but the study showed that just 15% to 20% of children will outgrow their allergy by the time they become adults. Gupta noted that more adults have peanut allergies than children.

Though a peanut allergy is generally considered a pediatric issue, many people don't develop one until after turning 18 years old.; "Given the high prevalence of peanut allergy among U.S. adults, additional therapies are needed to help address this growing burden of disease," Dr. Ruchi Gupta, director of the Center for Food Allergy and Asthma Research at Northwestern University, told UPI.